Christopher Brown, MD
Cardiovascular Disease · Mobile, ALNPI 1982685640
Payments from drug & device makers
Across 332 payments — averaging $4187.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$716K
- AstraZeneca$174K
- Novartis$156K
- Eli Lilly$154K
- Boehringer Ingelheim International GmbH$46K
- Bayer$43K
- plus $102K from 9 others
Across 2 payments — averaging $2355.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$5K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 35 | $715,507 |
| AstraZeneca | 16 | $174,234 |
| Novartis | 16 | $155,760 |
| Eli Lilly | 2 | $154,007 |
| Boehringer Ingelheim International GmbH | 146 | $45,826 |
| Bayer | 30 | $42,532 |
| Kowa Research Institute, Inc. | 32 | $41,089 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 3 | $22,942 |
| Esperion Therapeutics, Inc. | 35 | $18,642 |
| Amgen | 1 | $11,503 |
| Amarin Pharma, Inc. | 1 | $7,691 |
| Biotronik Inc. | 11 | $332 |
| Abiomed | 2 | $58 |
| Abbott | 1 | $25 |
| GSK | 1 | $18 |
How this compares
$1,390,166 in reported general payments places this provider in the 95th percentile of 292 cardiovascular disease providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Mobile
- Dennis ThomasMobile$894K
- Jason ColeMobile$131K
- Christopher MalozziMobile$111K
- Frank LesterMobile$96K
- John MorrowMobile$45K
- Mustafa AhmedBirmingham$2.5M
- Brian FoleyAlexander City$2.5M
- Andreas MuenchDothan$2M
- Alain BouchardBirmingham$1.9M
- William DavisAuburn$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.